Farms.com Home   News

Patience Is Waning For Iowa Farmers Impacted By Trade War

Patience Is Waning For Iowa Farmers Impacted By Trade War
China will exclude U.S. soybeans and pork from its latest round of tariffs, yet many Iowa farmers are concerned as the trade dispute continues to impact their bottom lines. 
 
David Differding and his wife Susan own Timeless Prairie Orchard, a small apple farm in Winthrop, Iowa. He says his business has lost tens of thousands of dollars as rising tariffs lead large-scale apple producers in Washington to flood the market with the lower priced produce they're unable to export.
 
Differding says farmers' patience is running out, which may show up in political opinion, and possibly even upcoming elections.
 
"This is business, and they have to realize that what they're doing to businesses across the United States and not just in Iowa is hurting everybody," Differding says. "And the markets that they've worked years to gain are not going to come back right away. And that's going to be the long term effect of what's happening."
 
 
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.